17 results on '"Luo, Dong"'
Search Results
2. Prognostic bleeding events in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy with half-dose recombinant human prourokinase: 2-year follow-up
3. A case of syncope caused by coronary spastic angina (CSA)
4. Tortuous diagnosis and treatment of a patient with coronary vasospastic angina(VSA)
5. Association between pharmaco-invasive strategy and serious procedure-related complication: A secondary analysis of the parmaco-invasive strategy with half-dose recombinant human prourokinase (PHDP) study
6. Effect of pharmaco-invasive strategy with half-dose recombinant human prourokinase on cardiac arrhythmias within 30 Days after percutaneous coronary intervention
7. Efficacy analysis of half-dose recombinant human prourokinase thromboiysis compined with early PCI in 48 patients with ST-segment-elevation myocardial infarction (STEMI)
8. The proper anesthesia for an 81-year-old woman undergoing total hysterectomy with respiratory dysfunction after COVID-19 infection.
9. Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction(STEMI) treated with pharmaco-invasive strategy with half–dose recombinant human prourokinase (PHDP): Two-year outcomes.
10. Treatment of intravenous thrombolysis with half-dose recombinant human prourokinase reduces the rate of tirofiban use during early routine catheterization period
11. The pharmaco-invasive strategy with half-dose recombinant human prourokinase in treating patients with acute ST-segment elevation myocardial infarction (STEMI): The 2-year follow-up of bleeding events
12. Effect of pharmacoinvasive therapy with half-dose prourokinase on adverse cardiovascular events during angiography or percutaneous coronary intervention
13. A case of syphilitic heart disease with abnormal left coronary opening
14. Association between pharmaco-invasive strategy and serious procedure-related complications: A secondary analysis of the parmacoinvasive strategy with half-dose recombinant human prourokinase (PHDP) study
15. Pharmaco-invasive strategy with half-dose recombinant human prourokinase (PHDP): One-year outcomes
16. Effect of pharmaco-invasive strategy with half-dose recombinant human prourokinase on cardiac arrhythmias within 30 Days after percutaneous coronary intervention
17. Efficacy of half-dose recombinant human prourokinase thrombolysis combined with early PCI in 48 patients with ST-segment-elevation myocardial infarction (STEMI)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.